Iridex (IRIX) Interest Coverage Ratio (2012 - 2013)
Iridex (IRIX) recorded quarterly Interest Coverage Ratio of 3.25 in Q4 2013, down 58.44% quarter-over-quarter from 7.82 in Q3 2013, and down 80.81% on a YoY basis from 16.94 in Q4 2012.
Iridex (IRIX) Interest Coverage Ratio (2012 - 2013) Analysis & Trends
Iridex's Interest Coverage Ratio history runs 2 years deep, the most recent figure standing at 3.25 for Q4 2013.
- In Q4 2013, Interest Coverage Ratio fell 80.81% year-over-year to 3.25; the TTM figure through Sep 2014 stood at 12.63 (up 6.01% YoY), while the FY2013 annual figure was 7.1, up 273.3% from the prior year.
- Interest Coverage Ratio was 3.25 for Q4 2013 at Iridex, down from 7.82 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 16.94 in Q4 2012 to a low of 7.29 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.98 |
| 10 | Iridex | 19.91 Mn | 15.31 Mn | 4.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 28, 2013 | 3.25 |
| Sep 28, 2013 | 7.82 |
| Jun 29, 2013 | 5.31 |
| Dec 29, 2012 | 16.94 |
| Sep 29, 2012 | -4.95 |
| Jun 30, 2012 | -7.29 |